230 related articles for article (PubMed ID: 12175311)
1. Effect of irradiation fluence rate on the efficacy of photodynamic therapy and tumor oxygenation in meta-tetra (hydroxyphenyl) chlorin (mTHPC)-sensitized HT29 xenografts in nude mice.
Coutier S; Bezdetnaya LN; Foster TH; Parache RM; Guillemin F
Radiat Res; 2002 Sep; 158(3):339-45. PubMed ID: 12175311
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy for malignant mesothelioma: preclinical studies for optimization of treatment protocols.
Schouwink H; Ruevekamp M; Oppelaar H; van Veen R; Baas P; Stewart FA
Photochem Photobiol; 2001 Apr; 73(4):410-7. PubMed ID: 11332037
[TBL] [Abstract][Full Text] [Related]
3. Foscan-based photodynamic treatment in vivo: correlation between efficacy and Foscan accumulation in tumor, plasma and leukocytes.
Maugain E; Sasnouski S; Zorin V; Merlin JL; Guillemin F; Bezdetnaya L
Oncol Rep; 2004 Sep; 12(3):639-45. PubMed ID: 15289849
[TBL] [Abstract][Full Text] [Related]
4. Influence of fractionation and fluence rate in photodynamic therapy with Photofrin or mTHPC.
van Geel IP; Oppelaar H; Marijnissen JP; Stewart FA
Radiat Res; 1996 May; 145(5):602-9. PubMed ID: 8619026
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of tetra(m-hydroxyphenyl)chlorin in the hamster cheek pouch tumor model: comparison with clinical measurements.
Glanzmann T; Forrer M; Blant SA; Woodtli A; Grosjean P; Braichotte D; van den Bergh H; Monnier P; Wagnières G
J Photochem Photobiol B; 2000 Aug; 57(1):22-32. PubMed ID: 11100834
[TBL] [Abstract][Full Text] [Related]
6. Outcome of mTHPC mediated photodynamic therapy is primarily determined by the vascular response.
Triesscheijn M; Ruevekamp M; Aalders M; Baas P; Stewart FA
Photochem Photobiol; 2005; 81(5):1161-7. PubMed ID: 15934792
[TBL] [Abstract][Full Text] [Related]
7. Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors.
Henderson BW; Gollnick SO; Snyder JW; Busch TM; Kousis PC; Cheney RT; Morgan J
Cancer Res; 2004 Mar; 64(6):2120-6. PubMed ID: 15026352
[TBL] [Abstract][Full Text] [Related]
8. Modality of cell death induced by Foscan-based photodynamic treatment in human colon adenocarcinoma cell line HT29.
Marchal S; Bezdetnaya L; Guillemin F
Biochemistry (Mosc); 2004 Jan; 69(1):45-9. PubMed ID: 14972017
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic properties of meta-tetra(hydroxyphenyl)chlorin in human tumor cells.
Melnikova VO; Bezdetnaya LN; Potapenko AY; Guillemin F
Radiat Res; 1999 Oct; 152(4):428-35. PubMed ID: 10477920
[TBL] [Abstract][Full Text] [Related]
10. Meta-tetra(hydroxyphenyl)chlorin-sensitized photodynamic damage of cultured tumor and normal cells in the presence of high concentrations of alpha-tocopherol.
Melnikova V; Bezdetnaya L; Belitchenko I; Potapenko A; Merlin JL; Guillemin F
Cancer Lett; 1999 May; 139(1):89-95. PubMed ID: 10408914
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of meta-tetrahydroxyphenylchlorin-sensitized photodynamic treatment on human tumor xenografts using a water-soluble vitamin E analogue, Trolox.
Melnikova VO; Bezdetnaya LN; Brault D; Potapenko AY; Guillemin F
Int J Cancer; 2000 Dec; 88(5):798-803. PubMed ID: 11072251
[TBL] [Abstract][Full Text] [Related]
12. Effects of fluence rate on cell survival and photobleaching in meta-tetra-(hydroxyphenyl)chlorin-photosensitized Colo 26 multicell tumor spheroids.
Coutier S; Mitra S; Bezdetnaya LN; Parache RM; Georgakoudi I; Foster TH; Guillemin F
Photochem Photobiol; 2001 Mar; 73(3):297-303. PubMed ID: 11281027
[TBL] [Abstract][Full Text] [Related]
13. Biodistribution and bioactivity of tetra-pegylated meta-tetra(hydroxyphenyl)chlorin compared to native meta-tetra(hydroxyphenyl)chlorin in a rat liver tumor model.
Rovers JP; Saarnak AE; de Jode M; Sterenborg HJ; Terpstra OT; Grahn MF
Photochem Photobiol; 2000 Feb; 71(2):211-7. PubMed ID: 10687396
[TBL] [Abstract][Full Text] [Related]
14. Optimisation of illumination for photodynamic therapy with mTHPC on normal colon and a transplantable tumour in rats.
Tsutsui H; MacRobert AJ; Curnow A; Rogowska A; Buonaccorsi G; Kato H; Bown SG
Lasers Med Sci; 2002; 17(2):101-9. PubMed ID: 12111593
[TBL] [Abstract][Full Text] [Related]
15. Inclusion complexation with β-cyclodextrin derivatives alters photodynamic activity and biodistribution of meta-tetra(hydroxyphenyl)chlorin.
Yankovsky I; Bastien E; Yakavets I; Khludeyev I; Lassalle HP; Gräfe S; Bezdetnaya L; Zorin V
Eur J Pharm Sci; 2016 Aug; 91():172-82. PubMed ID: 27320407
[TBL] [Abstract][Full Text] [Related]
16. Relationship between mTHPC fluorescence photobleaching and cell viability during in vitro photodynamic treatment of DP16 cells.
Dysart JS; Patterson MS; Farrell TJ; Singh G
Photochem Photobiol; 2002 Mar; 75(3):289-95. PubMed ID: 11950095
[TBL] [Abstract][Full Text] [Related]
17. In vivo fluence rate effect in photodynamic therapy of early cancers with tetra(m-hydroxyphenyl)chlorin.
Blant SA; Woodtli A; Wagnières G; Fontolliet C; van den Bergh H; Monnier P
Photochem Photobiol; 1996 Dec; 64(6):963-8. PubMed ID: 8972639
[TBL] [Abstract][Full Text] [Related]
18. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J
Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168
[TBL] [Abstract][Full Text] [Related]
19. Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model.
Rovers JP; Saarnak AE; Molina A; Schuitmaker JJ; Sterenborg HJ; Terpstra OT
Br J Cancer; 1999 Oct; 81(4):600-8. PubMed ID: 10574244
[TBL] [Abstract][Full Text] [Related]
20. Compartmental targeting for mTHPC-based photodynamic treatment in vivo: Correlation of efficiency, pharmacokinetics, and regional distribution of apoptosis.
Garrier J; Bressenot A; Gräfe S; Marchal S; Mitra S; Foster TH; Guillemin F; Bezdetnaya L
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):563-71. PubMed ID: 20656417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
